全文获取类型
收费全文 | 4192篇 |
免费 | 178篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 71篇 |
儿科学 | 145篇 |
妇产科学 | 122篇 |
基础医学 | 460篇 |
口腔科学 | 62篇 |
临床医学 | 303篇 |
内科学 | 1130篇 |
皮肤病学 | 118篇 |
神经病学 | 409篇 |
特种医学 | 133篇 |
外科学 | 501篇 |
综合类 | 9篇 |
预防医学 | 252篇 |
眼科学 | 47篇 |
药学 | 253篇 |
中国医学 | 12篇 |
肿瘤学 | 353篇 |
出版年
2023年 | 25篇 |
2022年 | 67篇 |
2021年 | 104篇 |
2020年 | 56篇 |
2019年 | 95篇 |
2018年 | 123篇 |
2017年 | 76篇 |
2016年 | 96篇 |
2015年 | 110篇 |
2014年 | 141篇 |
2013年 | 173篇 |
2012年 | 288篇 |
2011年 | 271篇 |
2010年 | 162篇 |
2009年 | 157篇 |
2008年 | 228篇 |
2007年 | 185篇 |
2006年 | 194篇 |
2005年 | 196篇 |
2004年 | 184篇 |
2003年 | 179篇 |
2002年 | 123篇 |
2001年 | 77篇 |
2000年 | 91篇 |
1999年 | 100篇 |
1998年 | 37篇 |
1997年 | 28篇 |
1996年 | 26篇 |
1995年 | 22篇 |
1994年 | 26篇 |
1993年 | 28篇 |
1992年 | 79篇 |
1991年 | 73篇 |
1990年 | 49篇 |
1989年 | 66篇 |
1988年 | 54篇 |
1987年 | 53篇 |
1986年 | 48篇 |
1985年 | 56篇 |
1984年 | 34篇 |
1983年 | 41篇 |
1982年 | 12篇 |
1981年 | 11篇 |
1979年 | 14篇 |
1978年 | 11篇 |
1977年 | 11篇 |
1972年 | 9篇 |
1971年 | 13篇 |
1970年 | 16篇 |
1969年 | 11篇 |
排序方式: 共有4380条查询结果,搜索用时 0 毫秒
991.
Mancini Manuele Cerroni Loredana Iorio Lorenzo Dall’Asta Lorenzo Cianconi Luigi 《Clinical oral investigations》2018,22(2):993-999
Clinical Oral Investigations - This study was to compare the efficacy of EndoActivator, EndoVac, PUI, and LAI methods in removing the smear layer from root canals. Eighty single-rooted mandibular... 相似文献
992.
993.
994.
J.M. van de Kamp A. Errami M. Howidi I. Anselm S. Winter J. Phalin‐Roque H. Osaka S.J.M. van Dooren G.M. Mancini S.J. Steinberg G.S. Salomons 《Clinical genetics》2015,87(2):141-147
The BCAP31 gene is located between SLC6A8, associated with X‐linked creatine transporter deficiency, and ABCD1, associated with X‐linked adrenoleukodystrophy. Recently, loss‐of‐function mutations in BCAP31 were reported in association with severe developmental delay, deafness and dystonia. We characterized the break points in eight patients with deletions of SLC6A8, BCAP31 and/or ABCD1 and studied the genotype–phenotype correlations. The phenotype in patients with contiguous gene deletions involving BCAP31 overlaps with the phenotype of isolated BCAP31 deficiency. Only deletions involving both BCAP31 and ABCD1 were associated with hepatic cholestasis and death before 1 year, which might be explained by a synergistic effect. Remarkably, a patient with an isolated deletion at the 3′‐end of SLC6A8 had a similar severe phenotype as seen in BCAP31 deficiency but without deafness. This might be caused by the disturbance of a regulatory element between SLC6A8 and BCAP31. 相似文献
995.
996.
Lenci I Angelico M Tisone G Orlacchio A Palmieri G Pinci M Bombardieri R Curatolo P 《Journal of hepatology》2008,48(6):1026-1029
BACKGROUND/AIMS: Isolated liver angiomyolipomas (AMLs) occur in about 40% of TSC patients. Because of their slow growth, these tumors are often asymptomatic. Since AMLs express estrogen and progesteron receptors we suggest the possible benefits of tamoxifen for the treatment of liver AMLs. METHODS: We report the case of a 26-year-old female affected by tuberous sclerosis (TSC2) with cerebral, renal and hepatic involvement admitted to the Liver Unit for severe malnutrition, anorexia and abdominal pain. MRI showed a grossly enlarged liver, causing severe gastric compression. The liver was entirely filled with multiple nodular lesions of different sizes. Liver biopsy showed tumoral tissue with microscopic and ultrastructural features of angiomyolipoma. All liver function tests were repeatedly normal. Prior to considering the patient for partial hepatectomy, she was administered tamoxifen (20mg b.i.d). RESULTS: After 6 months of tamoxifen treatment a greatly improved quality of life and a significant weight gain were observed. After 12 months the clinical conditions further improved and the MRI showed a significant reduction of the largest lesion with a liquid central area and a diminished compression of the stomach. CONCLUSIONS: This is to our knowledge the first report in which tamoxifen has been successfully used in a TSC patient with multiple liver angiomyolipomas. 相似文献
997.
Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations. 总被引:3,自引:0,他引:3
C Salvarani P Macchioni L Boiardi F Rossi M Casadei Maldini R Mancini E Beltrandi C Spacca L Lodi I Portioli 《The Journal of rheumatology》1992,19(7):1100-1106
Serum levels of soluble interleukin 2 receptors (sIL-2R) were measured in 21 patients with polymyalgia rheumatica (PMR)/giant cell arteritis (GCA) prior to steroid treatment. These levels were significantly elevated in patients with PMR/GCA compared with healthy controls (p = 0.002). A significantly longer duration of morning stiffness (p = 0.005) was observed in patients with a high concentration of sIL-2R. A significant correlation was observed at diagnosis between sIL-2R and erythrocyte sedimentation rate (ESR) (p = 0.01) and between ESR and C-reactive protein (CRP) (p = 0.005). We investigated prospectively a group of 10 patients over a period of 6 months of prednisone therapy. At the end of the study sIL-2R levels fell significantly compared to pretreatment values (p = 0.02), but remained significantly higher compared to controls (p = 0.02). ESR and CRP values also fell significantly compared to pretreatment levels (p = 0.0001 in both cases). We observed a significant correlation between the decrease in ESR values and the decrease in sIL-2R and CRP levels after 6 weeks (p = 0.01 in both cases) and after 6 months of therapy (p = 0.002 and p = 0.05). sIL-2R may be considered a useful serologic marker for monitoring response to steroid therapy in patients with PMR/GCA. This laboratory variable correlated more closely with ESR than with CRP. The presence of elevated levels of sIL-2R is likely to reflect T cell activation occurring in PMR/GCA. T lymphocyte activation persisted after 6 months of steroid therapy, despite rapid and continuous control of disease manifestations. 相似文献
998.
The effects of milrinone and captopril on ventricular performance, renal blood flow, and femoral vein oxygen content were compared in 11 patients with severe chronic heart failure. The increase in stroke volume index was greater with milrinone than with captopril (28 +/- 7 vs 24 +/- 7 ml/m2; p less than .05), while pulmonary capillary wedge pressures fell similarly (19 +/- 10 vs 21 +/- 7 mm Hg). Mean systemic arterial pressure decreased significantly from 84 +/- 10 to 73 +/- 11 mm Hg (p less than .05) with captopril but did not with milrinone. Neither drug changed heart rate significantly. Although milrinone produced a greater improvement in ventricular performance than captopril, renal blood flow increased similarly with both drugs from 289 +/- 78 to 417 +/- 111 ml/min (p less than .05) and from 278 +/- 77 to 441 +/- 115 ml/min (p less than .05), respectively. Femoral vein oxygen content was increased by milrinone from 7.9 +/- 2.6 to 9.8 +/- 3.0 ml/100 ml (p less than .05) and was not changed by captopril. In seven additional patients, intravenous milrinone, administered at the peak effect of captopril, further augmented stroke volume index from 24 +/- 6 to 32 +/- 6 ml/m2 (p less than .05) and tended to reduce pulmonary capillary wedge pressure further from 20 +/- 8 to 18 +/- 9 mm Hg (p = NS).(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
999.
Statin therapy and the management of acute coronary syndromes 总被引:6,自引:0,他引:6
Langer A Constance C Fodor JG Frohlich JJ Grégoire J Lau DC Leiter LA Mancini GB Marr D McPherson R O'Neill BJ Rabkin SW 《The Canadian journal of cardiology》2003,19(8):921-927
The pathophysiology of acute coronary syndromes is related to erosion or rupture of vulnerable plaque leading to intracoronary thrombosis as a result of activation of the coagulation cascade and platelet aggregation. Potential benefit of hypolipidemic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition may be related to the pleiotropic effects such as endothelial function improvement, stabilization of the plaque in relation to reduced macrophage activity and smooth muscle cell proliferation, as well as other anti-inflammatory effects that have been demonstrated in animal models. With the publication of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study, early initiation of statin therapy within 24 to 96 h has been recognized as an important addition to the therapeutic armamentarium in the management of patients with acute coronary syndromes. 相似文献
1000.
Enzo Lalli MD Dr. Riccardo Meliconi MD Roberto Conte MD Antonmaria Mancini MD Mariagrazia Uguccioni MD Giuseppe Francesco Stefanini MD Giovanni Gasbarrini MD 《Digestive diseases and sciences》1992,37(7):1116-1120
We monitored the immune response after liver transplantation in 20 patients by measuring the serum levels of soluble interleukin-2 receptor (sIL-2R), soluble CD8 (sCD8), serum amyloid-A protein (SAA), and tumor necrosis factor- (TNF-). In six patients data were available to extend the follow-up period to one year. In all patients mean sIL-2R levels increased in the first month after liver transplantation, and subsequently decreased to values similar to pre-OLT ones, while SAA mean levels rose in the first week after OLT only in patients with rejection. sCD8 levels did not significantly rise after OLT, and TNF- was undetectable in most cases. During episodes of rejection, rejector patients had significantly higher levels of sIL-2R, sCD8, and SAA than stable (without complications) patients. Conversely, no significant difference between rejectors and patients with other complications existed for any of the markers studied. These results diminish the importance of these serum markers of immune activation as laboratory tools in the differential diagnosis of acute rejection from other complications. However, sIL-2R, SAA, and sCD8 levels correlated with the histological grade of rejection and therefore can be utilized to monitor patients with an established diagnosis of acute rejection. 相似文献